CAMZYOS 15mg capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE
Chemical substance: mavacamten
ATC code: C01EB24 • Cardiovascular system | Other cardiac preparations
Active substance
Results for the substance mavacamten
4 results
About this active substance
Mavacamten is a medication used for the treatment of obstructive hypertrophic cardiomyopathy (HCM). It works by selectively inhibiting myosin, reducing excessive contractility of the heart muscle.
The medication is taken orally, usually once daily, and is intended for patients with moderate to severe symptoms. It is important to monitor cardiac function during treatment to avoid complications.
Side effects may include dizziness, fatigue, or headaches. In rare cases, heart failure or other cardiac-related issues may occur.
Mavacamten is not recommended for patients with severe heart failure or those taking medications that interact with myosin metabolism.
The medication is taken orally, usually once daily, and is intended for patients with moderate to severe symptoms. It is important to monitor cardiac function during treatment to avoid complications.
Side effects may include dizziness, fatigue, or headaches. In rare cases, heart failure or other cardiac-related issues may occur.
Mavacamten is not recommended for patients with severe heart failure or those taking medications that interact with myosin metabolism.
-
-
CAMZYOS 5mg capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE
Chemical substance: mavacamten
ATC code: C01EB24 • Cardiovascular system | Other cardiac preparations
-
CAMZYOS 2.5mg capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE
Chemical substance: mavacamten
ATC code: C01EB24 • Cardiovascular system | Other cardiac preparations
-
CAMZYOS 10mg capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE
Chemical substance: mavacamten
ATC code: C01EB24 • Cardiovascular system | Other cardiac preparations